APA

Rager A., Frey N., Goldstein S. C., Reshef R., Hexner E. O., Loren A., Luger S. M., Perl A., Tsai D., Davis J., Vozniak M., Smith J., Stadtmauer E. A. & Porter D. L. (20110804). Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD. : Bone marrow transplantation.

Chicago

Rager A, Frey N, Goldstein S C, Reshef R, Hexner E O, Loren A, Luger S M, Perl A, Tsai D, Davis J, Vozniak M, Smith J, Stadtmauer E A and Porter D L. 20110804. Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD. : Bone marrow transplantation.

Harvard

Rager A., Frey N., Goldstein S. C., Reshef R., Hexner E. O., Loren A., Luger S. M., Perl A., Tsai D., Davis J., Vozniak M., Smith J., Stadtmauer E. A. and Porter D. L. (20110804). Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD. : Bone marrow transplantation.

MLA

Rager A, Frey N, Goldstein S C, Reshef R, Hexner E O, Loren A, Luger S M, Perl A, Tsai D, Davis J, Vozniak M, Smith J, Stadtmauer E A and Porter D L. Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD. : Bone marrow transplantation. 20110804.